Manulife (Manufacturers Life Insurance)
AUPH icon

Manulife (Manufacturers Life Insurance)’s Aurinia Pharmaceuticals AUPH Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$476K Sell
32,090
-3,736
-10% -$54.6K ﹤0.01% 2178
2025
Q4 		$571K Sell
35,826
-2,130
-6% -$30.2K ﹤0.01% 2118
2025
Q3 		$419K Sell
37,956
-2,416
-6% -$26.4K ﹤0.01% 2279
2025
Q2 		$342K Sell
40,372
-5,419
-12% -$43.4K ﹤0.01% 2333
2025
Q1 		$368K Sell
45,791
-659
-1% -$5.34K ﹤0.01% 2274
2024
Q4 		$417K Sell
46,450
-1,100
-2% -$8.97K ﹤0.01% 2324
2024
Q3 		$349K Sell
47,550
-5,197
-10% -$32.2K ﹤0.01% 2410
2024
Q2 		$301K Buy
52,747
+4,808
+10% +$25.3K ﹤0.01% 2422
2024
Q1 		$240K Sell
47,939
-1,645
-3% -$11.2K ﹤0.01% 2507
2023
Q4 		$446K Sell
49,584
-923
-2% -$7.6K ﹤0.01% 2224
2023
Q3 		$392K Buy
50,507
+31
+0.1% +$303 ﹤0.01% 2254
2023
Q2 		$489K Buy
50,476
+1,014
+2% +$10.5K ﹤0.01% 2050
2023
Q1 		$542K Hold
49,462
– – ﹤0.01% 1967
2022
Q4 		$214K Sell
49,462
-268
-0.5% -$1.55K ﹤0.01% 2529
2022
Q3 		$374K Sell
49,730
-892
-2% -$7.72K ﹤0.01% 2162
2022
Q2 		$509K Buy
+50,622
New +$566K ﹤0.01% 2049
2021
Q3 		– Sell
-109,845
Closed -$1.76M – 3150
2021
Q2 		$1.76M Sell
109,845
-4,766
-4% -$60.7K ﹤0.01% 1664
2021
Q1 		$1.87M Sell
114,611
-2,800
-2% -$40.6K ﹤0.01% 1572
2020
Q4 		$2.06M Sell
117,411
-1,019
-0.9% -$14.8K ﹤0.01% 1526
2020
Q3 		$2.32M Buy
118,430
+12,592
+12% +$182K ﹤0.01% 1388
2020
Q2 		$2M Buy
+105,838
New +$1.69M ﹤0.01% 1399

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s AUPH Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Aurinia Pharmaceuticals (AUPH) stake by 10% in Q1 2026, selling an estimated $54.6K and leaving 32,090 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #2178.

Manulife (Manufacturers Life Insurance) first reported a position in AUPH in Q2 2020 and has held it in 21 quarters since. The position peaked at $2.32M in Q3 2020. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 32,090 shares of Aurinia Pharmaceuticals worth $476K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 3,736 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $54.6K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2178 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Aurinia Pharmaceuticals in Q2 2020 and has held it in 21 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Aurinia Pharmaceuticals position peaked at $2.32M in Q3 2020.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.